Cargando…

Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development

Myopia is recognized as a multifactor, multicascade complex disease. However, people still know little about the pathogenesis of myopia. Therefore, we aim to guide the personalized treatment, drug research, and development of myopia. Here, based on the interaction network of myopia-related genes, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiliang, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110184/
https://www.ncbi.nlm.nih.gov/pubmed/35586671
http://dx.doi.org/10.1155/2022/5262259
_version_ 1784709045508112384
author Liu, Shiliang
Li, Fei
author_facet Liu, Shiliang
Li, Fei
author_sort Liu, Shiliang
collection PubMed
description Myopia is recognized as a multifactor, multicascade complex disease. However, people still know little about the pathogenesis of myopia. Therefore, we aim to guide the personalized treatment, drug research, and development of myopia. Here, based on the interaction network of myopia-related genes, this study constructed a multifactor-driven myopia disease module map. We first identified differentially expressed (DE) miRNAs in myopia. Then, we constructed a myopia-related protein interaction network targeted by these DE miRNAs. Further, we clustered the network into modules and identified module-driven factors, including ncRNAs and transcription factors. Especially, miR-16-5p and miR-34b-5p significantly differentially expressed drive the pathogenic module to influence the progression of myopia. At the same time, transcription factors were involved in myopia-related functions and pathways by regulating the expression of genes in modules, such as Ctnnb1, Myc, and Notch1. In addition, we identified 43 genes in modules that played key roles in the development and progression of myopia such as Vamp2, Egfr, and Wasl. Finally, we constructed a comprehensive multifactor-driven myopia pathogenic module landscape and predicted potential drug and drug targets for myopia. In general, our work not only provided candidates for biological experiments which laid the foundation for the in-depth study of myopia but also has a high reference value for the personalized treatment of myopia and drug development.
format Online
Article
Text
id pubmed-9110184
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91101842022-05-17 Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development Liu, Shiliang Li, Fei Comput Math Methods Med Research Article Myopia is recognized as a multifactor, multicascade complex disease. However, people still know little about the pathogenesis of myopia. Therefore, we aim to guide the personalized treatment, drug research, and development of myopia. Here, based on the interaction network of myopia-related genes, this study constructed a multifactor-driven myopia disease module map. We first identified differentially expressed (DE) miRNAs in myopia. Then, we constructed a myopia-related protein interaction network targeted by these DE miRNAs. Further, we clustered the network into modules and identified module-driven factors, including ncRNAs and transcription factors. Especially, miR-16-5p and miR-34b-5p significantly differentially expressed drive the pathogenic module to influence the progression of myopia. At the same time, transcription factors were involved in myopia-related functions and pathways by regulating the expression of genes in modules, such as Ctnnb1, Myc, and Notch1. In addition, we identified 43 genes in modules that played key roles in the development and progression of myopia such as Vamp2, Egfr, and Wasl. Finally, we constructed a comprehensive multifactor-driven myopia pathogenic module landscape and predicted potential drug and drug targets for myopia. In general, our work not only provided candidates for biological experiments which laid the foundation for the in-depth study of myopia but also has a high reference value for the personalized treatment of myopia and drug development. Hindawi 2022-05-09 /pmc/articles/PMC9110184/ /pubmed/35586671 http://dx.doi.org/10.1155/2022/5262259 Text en Copyright © 2022 Shiliang Liu and Fei Li. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Shiliang
Li, Fei
Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development
title Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development
title_full Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development
title_fullStr Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development
title_full_unstemmed Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development
title_short Analysis of Multifactor-Driven Myopia Disease Modules to Guide Personalized Treatment and Drug Development
title_sort analysis of multifactor-driven myopia disease modules to guide personalized treatment and drug development
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110184/
https://www.ncbi.nlm.nih.gov/pubmed/35586671
http://dx.doi.org/10.1155/2022/5262259
work_keys_str_mv AT liushiliang analysisofmultifactordrivenmyopiadiseasemodulestoguidepersonalizedtreatmentanddrugdevelopment
AT lifei analysisofmultifactordrivenmyopiadiseasemodulestoguidepersonalizedtreatmentanddrugdevelopment